Induced pluripotent stem cells from a transgenic minipig model of Huntington's disease reveal early metabolic changes
Disease Models & Mechanisms · 01.06.2026 · 19 (6)
DOI: 10.1242/dmm.052585 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease Models & Mechanisms, online erschienen am 11.05.2026. Verfasst von Irena Rysankova und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital …. Hauptthemen laut MEDLINE: Huntington Disease, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CHDI Foundation, Akademie Věd České Republiky, Ministerstvo Školství, Mládeže a Tělovýchovy.
Abstract (Originalsprache)
Huntington's disease (HD) is a neurodegenerative autosomal dominant hereditary disease caused by a CAG triplet repeat expansion mutation in the gene encoding the huntingtin (HTT) protein. The main feature of HD is the loss of striatal neurons, accompanied by metabolic and transcriptional alterations in both neural and peripheral tissues. Induced pluripotent stem cells (iPSCs) derived from a transgenic HD (TgHD) minipig model expressing a mutant HTT construct were generated to investigate early metabolic, antioxidant and DNA integrity changes associated with HD development. Gene expression analysis showed increased expression of vascular endothelial growth factor (VEGF), pyruvate dehydrogenase kinase 1 (PDK1) and glutamine-oxaloacetic transaminase 1 (GOT1), implying early metabolic alteration in TgHD iPSCs. Moreover, upregulated FANCD2/FANCI-associated nuclease 1 (FAN1) expression indicated genotoxic stress linked to early HD development. These findings suggest metabolic shifts and putative genotoxic events in the pluripotent stem cell state of the TgHD model and point to early effect of the HD mutation. The model may be suitable for evaluating potential cell therapy and in vitro differentiation of iPSCs to neurons and other cells affected in HD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, 120 00 Prague, Czech Republic.
- Laboratory of Cell Regeneration and Plasticity, Institute of Animal Physiology and Genetics of the Czech Academy of Science, 277 21 Libechov, Czech Republic.
- Department of Cell Biology, Faculty of Science, Charles University in Prague, 128 00 Prague, Czech Republic.
- Laboratory for Study of Mitochondrial Disorders, Department of Paediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, 12108 Prague 2, Czech Republic.
- Laboratory of Applied Proteome Analyses, Institute of Animal Physiology and Genetic of the Czech Academy of Sciences, 277 21 Libechov, Czech Republic.
- Laboratory of DNA integrity, Institute of Animal Physiology and Genetics of the Czech Academy of Science, 277 21 Libechov, Czech Republic.
ORCID-Profile: Zdenka Ellederova
Förderung
- CHDI Foundation
- Akademie Věd České Republiky
- Ministerstvo Školství, Mládeže a Tělovýchovy
- Univerzita Karlova v Praze
- Ministerstvo Zdravotnictví Ceské Republiky
- Ústav živocišné fyziologie a genetiky AV CR
- EU Joint Programme - Neurodegenerative Disease Research
- European Reference Network for Rare Neurological Diseases
Zitieren
APA
Rysankova, I., Sekac, D., Hansikova, H., Kepkova, K. V., Vodicka, P., Vaskovicova, M., Altmanova, M., Juhas, S., Juhasova, J., Taborska, E., Klempir, J., Motlik, J., Klima, J., Eide, L., & Ellederova, Z. (2026). Induced pluripotent stem cells from a transgenic minipig model of Huntington's disease reveal early metabolic changes. Disease Models & Mechanisms, 19(6). https://doi.org/10.1242/dmm.052585
Vancouver
Rysankova I, Sekac D, Hansikova H, Kepkova KV, Vodicka P, Vaskovicova M, et al. Induced pluripotent stem cells from a transgenic minipig model of Huntington's disease reveal early metabolic changes. Disease Models & Mechanisms. 2026;19(6). doi:10.1242/dmm.052585
BibTeX
@article{Rysankova2026,
author = {Rysankova, Irena and Sekac, David and Hansikova, Hana and Kepkova, Katerina Vodickova and Vodicka, Petr and Vaskovicova, Michaela and Altmanova, Marie and Juhas, Stefan and Juhasova, Jana and Taborska, Eliska and Klempir, Jiri and Motlik, Jan and Klima, Jiri and Eide, Lars and Ellederova, Zdenka},
title = {Induced pluripotent stem cells from a transgenic minipig model of Huntington's disease reveal early metabolic changes},
journal = {Disease Models & Mechanisms},
year = {2026},
volume = {19},
number = {6},
doi = {10.1242/dmm.052585}
}
EUVIMED